Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PREP | P48147 | 6/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.44 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9537217 | 0.86 | PREP (0.48) | PREPNPC1RAB9AL3MBTL1 | |
| SCHEMBL8637353 | 0.85 | PREP (0.44) | PREP | |
| Z-Pro-Prolinal SCHEMBL1219336 | 0.83 | PREP (0.67) | PREPL3MBTL1 | |
| Z-Pro-Prolinal SCHEMBL1380758 | 0.83 | PREP (0.67) | PREPL3MBTL1 | |
| Z-Pro-Prolinal SCHEMBL7272251 | 0.83 | PREP (0.67) | PREPL3MBTL1 | |
| SCHEMBL8639445 | 0.81 | PREP (0.65) | PREPL3MBTL1 | |
| SCHEMBL9964899 | 0.80 | NPC1 (0.53) | NPC1RAB9AL3MBTL1TMEM97SIGMAR1 | |
| SCHEMBL2195118 | 0.80 | PREP (0.56) | PREPNPC1RAB9AL3MBTL1 | |
| SCHEMBL2198909 | 0.80 | PREP (0.56) | PREPNPC1RAB9AL3MBTL1 | |
| SCHEMBL2198876 | 0.80 | PREP (0.56) | PREPNPC1RAB9AL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5847155-A | Aromatic pyrrolidine amide prolyl endopeptidase inhibitors | PFIZER INC (US) | 1998-12-08 | — | — | US | disclosed |
| WO-1991018891-A1 | AROMATIC PYRROLIDINE AND THIAZOLIDINE AMIDES | PFIZER INC. (US) | 1991-12-12 | — | — | WO | disclosed |